Objectives:
1. Explain the indications and contraindications to the NuPulse iVAS for long-term-support for patients with heart failure
2. Compare demonstrated outcomes for patients with the NuPulse iVAS versus other treatment modalities.
3. Assess the evolution of and current state of VAD devices and hypothesize future potential areas for innovation.
Session date:
04/17/2018 - 6:45am to 7:45am CDT
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Valluvan Jeevanandam, MD